These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 418697)
41. Hemolytic disease of the fetus and neonate. Brans YW Compr Ther; 1976 Apr; 2(4):42-7. PubMed ID: 944118 [No Abstract] [Full Text] [Related]
42. [Spectrophotometry of amniotic fluid in Rhesus sensibilization]. Havlová S; Radocha K Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1971; 14(4):463-8. PubMed ID: 5003885 [No Abstract] [Full Text] [Related]
43. [Changes in the spectrophotometric curve of amniotic fluid in severe fetal Rh-hemolytic disease (fetal and neonatal death)]. Matrova Ts Akush Ginekol (Sofiia); 1982; 21(5):387-91. PubMed ID: 6817650 [No Abstract] [Full Text] [Related]
44. [Methods for the determination of bilirubin in the amniotic fluid in Rhesus incompatibility]. Schultze-Mosgau H; Fischer K Med Monatsschr; 1970 Jan; 24(1):10-2. PubMed ID: 5004072 [No Abstract] [Full Text] [Related]
45. [Our experience with the pre- and postnatal diagnosis of ABO-hemolytic disease of the newborn]. Novachev D; Markov L; Antonov L; Tankov Ts Akush Ginekol (Sofiia); 1977; 16(5):317-26. PubMed ID: 413455 [No Abstract] [Full Text] [Related]
50. [The antenatal diagnosis of hemolytic diseases of the fetus, based on the determination of optic density of the amniotic fluid and on the choice of delivery time]. Sadauskas VM; Svigris AIu; Baliutavichene DA Akush Ginekol (Mosk); 1975 Feb; (2):35-8. PubMed ID: 814828 [No Abstract] [Full Text] [Related]
51. The applications and complications of diagnostic amniocentesis. Grobbelaar BG; Trott EL S Afr Med J; 1968 Jul; 42(27):687-92. PubMed ID: 4970612 [No Abstract] [Full Text] [Related]
52. [Bilirubin in amniotic fluid during the last month of pregnancy. Its value for prognosis in women immunized by Rhesus factors]. Baudelot J; Santarelli J; Duval C J Gynecol Obstet Biol Reprod (Paris); 1972 Dec; 1(8):805-13. PubMed ID: 4634173 [No Abstract] [Full Text] [Related]
53. Diagnosis of fetal death in utero by elevated amniotic fluid CPK levels. Kerenyi T; Sarkozi L Obstet Gynecol; 1974 Aug; 44(2):215-8. PubMed ID: 4841956 [No Abstract] [Full Text] [Related]
54. Management of the Rh-negative mother. Beck RP Can Med Assoc J; 1973 Nov; 109(9):903-4. PubMed ID: 4127213 [No Abstract] [Full Text] [Related]
55. The value of different methods of amniotic fluid analysis in the diagnosis of Rh hemolytic disease (spectrophotometric and chemical determination of bilirubin, bilirubin-protein ratio, anti-Rho(D) titres). Dambrosio F; Della Torre L; Meroni P; Clerici-Bagozzi D Ann Ostet Ginecol Med Perinat; 1970 Aug-1971 Aug; 92(8):528-31. PubMed ID: 5001775 [No Abstract] [Full Text] [Related]
56. [Blood lactate dehydrogenase activity in newborns with hemolytic disease due to Rh and ABO-incompatibility]. Dobronravov AV Vopr Okhr Materin Det; 1969 Jan; 14(1):33-8. PubMed ID: 4976718 [No Abstract] [Full Text] [Related]
57. Management of pregnancy complicated by Rh-immunization. Review with respect to own investigations and results. Bartsch FK Pathologica; 1972; 64(929):139-48. PubMed ID: 4210413 [No Abstract] [Full Text] [Related]
58. Amniocentesis in management of the Rh problem. Niswander KR; Westphal MC; Seekree S Obstet Gynecol; 1967 Nov; 30(5):646-51. PubMed ID: 4964059 [No Abstract] [Full Text] [Related]